Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,810 | 909 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 3 | 0.9% |
| Education | $147.85 | 9 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,009 | 107 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,738 | 61 | $0 (2022) |
| ABBVIE INC. | $1,242 | 69 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,138 | 76 | $0 (2022) |
| Amarin Pharma Inc. | $968.58 | 57 | $0 (2022) |
| Amgen Inc. | $948.94 | 44 | $0 (2022) |
| PFIZER INC. | $873.66 | 78 | $0 (2022) |
| Lilly USA, LLC | $826.67 | 53 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $759.77 | 40 | $0 (2022) |
| Allergan, Inc. | $671.10 | 60 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $3,152 | 161 | ABBVIE INC. ($396.49) |
| 2021 | $3,290 | 177 | AbbVie Inc. ($616.87) |
| 2020 | $2,124 | 114 | Novo Nordisk Inc ($401.19) |
| 2019 | $2,376 | 151 | GlaxoSmithKline, LLC. ($417.80) |
| 2018 | $1,841 | 105 | AstraZeneca Pharmaceuticals LP ($386.34) |
| 2017 | $3,325 | 213 | Novo Nordisk Inc ($526.55) |
All Payment Transactions
921 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Gastroenterology | ||||||
| 12/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes Care | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Gastroenterology | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $104.82 | General |
| 11/15/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 11/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 11/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Cardio-renal | ||||||
| 11/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardio-renal | ||||||
| 11/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 10/31/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Urology | ||||||
| 10/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: DIABETES | ||||||
| 10/24/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Respiratory | ||||||
| 10/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiovascular | ||||||
| 10/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: PRIMARY CARE | ||||||
| 10/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 10/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: PRIMARY CARE | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 14 | 838 | 1,100 | $123,926 | $28,316 |
| 2021 | 22 | 1,082 | 1,402 | $160,459 | $70,356 |
| 2020 | 19 | 974 | 1,298 | $121,184 | $50,990 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 232 | $38,280 | $8,890 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 94 | $21,996 | $4,197 | 19.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $23,601 | $3,347 | 14.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 49 | $6,305 | $3,280 | 52.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 93 | 93 | $2,883 | $1,632 | 56.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 92 | 92 | $2,852 | $1,587 | 55.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 51 | $2,448 | $1,428 | 58.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 66 | 130 | $3,380 | $1,214 | 35.9% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 12 | 30 | $2,490 | $796.38 | 32.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 35 | 35 | $1,470 | $604.70 | 41.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 103 | 103 | $15,965 | $559.97 | 3.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 11 | 12 | $1,416 | $367.87 | 26.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 53 | 56 | $672.00 | $336.16 | 50.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 12 | 24 | $168.00 | $76.20 | 45.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 131 | 291 | $47,085 | $16,724 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 114 | 114 | $26,010 | $14,410 | 55.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 110 | 110 | $17,050 | $8,702 | 51.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 86 | $19,764 | $6,795 | 34.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 62 | 62 | $7,540 | $4,038 | 53.5% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 12 | 12 | $3,984 | $2,852 | 71.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 11 | $4,708 | $2,376 | 50.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 111 | 111 | $3,441 | $1,941 | 56.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 104 | 104 | $3,224 | $1,825 | 56.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $3,150 | $1,751 | 55.6% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 25 | 27 | $3,186 | $1,717 | 53.9% |
About Dr. William Schukay, DO
Dr. William Schukay, DO is a Family Medicine healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952318305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Schukay, DO has received a total of $16,108 in payments from pharmaceutical and medical device companies, with $3,152 received in 2022. These payments were reported across 921 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($15,810).
As a Medicare-enrolled provider, Schukay has provided services to 2,894 Medicare beneficiaries, totaling 3,800 services with total Medicare billing of $149,662. Data is available for 3 years (2020–2022), covering 55 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cuyahoga Falls, OH
- Active Since 08/01/2006
- Last Updated 09/22/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952318305
Products in Payments
- Vascepa (Drug) $968.58
- FARXIGA (Drug) $967.09
- VRAYLAR (Drug) $753.61
- NURTEC ODT (Drug) $737.12
- Saxenda (Drug) $473.43
- Ozempic (Drug) $471.06
- UBRELVY (Drug) $461.01
- XARELTO (Drug) $456.56
- BREZTRI (Drug) $382.30
- TRULICITY (Drug) $362.54
- TRELEGY ELLIPTA (Drug) $356.29
- Aimovig (Biological) $352.03
- JARDIANCE (Drug) $335.27
- XIFAXAN (Drug) $329.39
- INVOKANA (Drug) $297.19
- Victoza (Drug) $295.90
- SOLIQUA 100/33 (Biological) $287.10
- ENTRESTO (Drug) $262.37
- RYBELSUS (Drug) $254.99
- ELIQUIS (Drug) $254.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cuyahoga Falls
Dr. Tricia Bedrick, D.o, D.O
Family Medicine — Payments: $223,294
Muhamad Musa, M.d, M.D
Family Medicine — Payments: $19,605
Dr. Scott Higley, D.o, D.O
Family Medicine — Payments: $16,424
James Johnston, D.o, D.O
Family Medicine — Payments: $15,241
Victoria Digennaro, D.o, D.O
Family Medicine — Payments: $13,874
Andrea Cerone, M.d, M.D
Family Medicine — Payments: $12,005